The Century of Biology
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
What Are Virtual Cells?
Learning "universal representations" of life's fundamental unit
Jun 29
•
Elliot Hershberg
89
10
March 2025
On Modality Commoditization
And what might come next
Mar 16
•
Elliot Hershberg
114
5
February 2025
Hub-and-Spoke Biotechs: BridgeBio
Attempting "Moneyball for biotech"
Feb 16
•
Elliot Hershberg
85
17
October 2024
Hub-and-Spoke Biotechs: Nimbus Therapeutics
Building an "evergreen" drug discovery engine
Oct 20, 2024
•
Elliot Hershberg
59
16
September 2024
Living Carbon: Photosynthesis-Enhanced Trees
Why and how to engineer trees; climate biotech business strategy
Sep 22, 2024
•
Elliot Hershberg
63
17
June 2024
A Summer Hiatus
Pausing before scaling
Jun 23, 2024
•
Elliot Hershberg
56
9
Scaling CRISPR Cures
Realizing the potential of genetic medicine
Jun 2, 2024
•
Elliot Hershberg
60
17
May 2024
Generating (Somewhat) New Biology with AI
Using protein language models for Digital Evolution
May 5, 2024
•
Elliot Hershberg
55
16
April 2024
Compounding Until Inflection
Present vs. future platform value
Apr 14, 2024
•
Elliot Hershberg
35
2
March 2024
Beyond Steel Tanks
GLP-1 drugs could one day outsell iPhones, but there is not enough biomanufacturing capacity to make them. For solutions, we should look away from the…
Published on Asimov Press
•
Mar 24, 2024
February 2024
New tools for programming biology
Continuous mutagenesis, RNA writing, and more
Feb 18, 2024
•
Elliot Hershberg
70
9
January 2024
Spill the TEA
Making economically viable bioproducts
Jan 28, 2024
•
Elliot Hershberg
58
13
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts